Cryotherapy as an adjunct to systemic antimonials for cutaneous leishmaniasis in children.
Stavropoulos
P G
PG
Papakonstantinou
A-M
AM
Petropoulou
H
H
Kontochristopoulos
G
G
Katsambas
A
A
D000293:Adolescent; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D002648:Child; D003131:Combined Modality Therapy; D017679:Cryotherapy; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D016773:Leishmaniasis, Cutaneous / Q000473:pathology / Q000628:therapy*; D008297:Male; D008536:Meglumine / Q000627:therapeutic use*; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use*; D012867:Skin / Q000473:pathology
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate